|Day Low/High||373.56 / 381.31|
|52 Wk Low/High||244.10 / 389.50|
This is hope, not fact -- don't pay more for the same old thing.
There are signs in the market that the talks may not be going as well as thought, or at least that some believe that Trump thinks he has the upper hand.
However, the RMPIA did not see as much improvement last month as some other market indices.
Here are a host of stocks that will benefit from a deal, and why you should pick them up on a selloff.
The IT hardware giant beat EPS estimates with the help of margin growth and buybacks. But revenue fell short amid lower server and IT services sales.
The RMPIA rose 10.5% during the first half of the current quarter.
Many see the Fed as done for the year. Never assume. Read the words as they are written.
This shutdown is starting to feel different from those that we have experienced in the past, is it not?
It sure felt like that after listening to Citigroup's robust conference call this morning.
We are going to have to differentiate retail and recognize that Wall Street tolerates nothing disappointing.
The Fed now appears to me, to be if not in the 'policy error' zone than very close to it. Perhaps the Treasury Secretary sees this as well.
Buoying RMPIA during the first half of December were shares of Broadcom, Facebook and PayPal.
But there is no catalyst right now, and there are so many other sectors with better prospects.
What else can you say about a decision by the Chinese that amounts to a potential repudiation of the Made in China 2025 plan?
For the month of November RMPIA climbed 1.2% month over month.
What to buy and what to trim on the 90-day extension on trade talks.
Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.
FANG stocks, Mastercard and Visa, among others, are all feeling the impact.
Some groups that have been in horrendous bear market mode finally caught a bid.
My target price and panic points have changed, and I am watching for a chance to add or shave some off, depending on which direction the stock takes.
For most of this year the market has been led by growth stocks.
A new report indicates only a few dozen institutions have been willing to take the risk of serving marijuana-related businesses in earnest.
Let's see what the updated charts and indicators look like now.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
I recognize that the struggle is the risk to owning value, and not the other way around.
The love for payments, any payments, knows no bounds.